IPRIPR2025-01107Discretionary Denial
MSN Pharmaceuticals, Inc. et al.v.Breckenridge Pharmaceutical, Inc.
IPR challenge of US 11013729.
Type
IPR
Filed
Jun 6, 2025
Instituted
Oct 17, 2025
Decided
Oct 17, 2025
Patent
Application
14379613
Inventor
Pratibha S. Pilgaonkar et al
Granted
May 25, 2021
01
Timeline
3 milestones
2025-06-06Petition filed
2025-10-17Institution
2025-10-17Terminated
02
Parties & counsel
Petitioner
MSN Pharmaceuticals, Inc. et al.
Counsel
Torabi, Noorossadatet al
Patent Owner
Breckenridge Pharmaceutical, Inc.
Counsel
Larsen, Andrewet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →